Digipath
Home > Boards > US OTC > Medical - Equipment > Arrayit Corporation (ARYC)

Sunnyvale, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Arrayit

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
mikeo56 Member Profile
 
Followed By 80
Posts 8,725
Boards Moderated 0
Alias Born 01/10/04
160x600 placeholder
Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider GlobeNewswire Inc. - 12/3/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health GlobeNewswire Inc. - 11/19/2018 5:30:00 AM
Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing GlobeNewswire Inc. - 11/5/2018 5:30:00 AM
Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business GlobeNewswire Inc. - 11/1/2018 5:30:00 AM
Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics GlobeNewswire Inc. - 10/22/2018 5:30:00 AM
Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists GlobeNewswire Inc. - 10/8/2018 5:30:00 AM
Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration GlobeNewswire Inc. - 9/24/2018 5:30:00 AM
Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services GlobeNewswire Inc. - 9/10/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers GlobeNewswire Inc. - 8/27/2018 5:30:00 AM
Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain GlobeNewswire Inc. - 8/13/2018 5:30:00 AM
Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics GlobeNewswire Inc. - 7/30/2018 5:30:00 AM
Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration GlobeNewswire Inc. - 7/16/2018 5:30:00 AM
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains GlobeNewswire Inc. - 7/2/2018 5:30:00 AM
Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network GlobeNewswire Inc. - 6/18/2018 5:30:00 AM
Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement GlobeNewswire Inc. - 5/30/2018 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/9/2018 1:55:34 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/22/2018 2:12:50 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/19/2018 6:37:10 PM
mikeo56   Monday, 01/14/19 09:44:20 AM
Re: None
Post # of 118013 
Sunnyvale, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, reports that its clinical team has aced four consecutive rounds of proficiency testing (PT) with a nationally recognized proficiency testing leader. Proficiency testing requires precise quantification of specific cellular immunoglobulin E (IgE) antibodies, the protein biomarkers often associated with allergy and asthma. PT samples are blind-tested for IgE concentration as a means of evaluating the accuracy of a clinical test. Arrayit’s clinical team aced four consecutive rounds of PT over a 12-month period, indicating that its microarray testing technology is highly accurate when assessed by an independent third party. Accurate IgE quantification confirms the numerical validity of the company’s allergy test results, which are being increasingly used by doctors and clinics to diagnose, manage and treat patients with allergy and asthma. Outstanding PT scores are important because they facilitate reimbursement by government payors such as the Centers of Medicare and Medicaid Services (CMS) and commercial health insurance providers.

Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the FDA regarding approval of a major product line, fulfilled an FDA clinical instrumentation contract, signed allergy testing contracts with more than 300 medical clinics, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing by CMS, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, announced an allergy testing services agreement with a major health and wellness provider and provided a letter to shareholders from the company’s Chief Executive Officer (CEO).

CEO Rene Schena states, “The outstanding proficiency testing performance of our clinical laboratory confirms and extends the accuracy of our allergy testing services over time, and indicates that our doctor-ordered allergy tests provide clinical quality, actionable medical information for physicians treating allergy and asthma patients. The accuracy and convenience of our finger stick health and wellness tests has significant impact as we address an increasing number of healthcare providers in diverse market sectors including physician groups, clinics, hospitals, health maintenance organizations (HMOs), hospitals and large retail chains.

Years Teach Us, Which Days Never Knew
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist